Company Quick10K Filing
Ando Holdings
10-Q 2020-03-31 Filed 2020-05-14
10-Q 2019-12-31 Filed 2020-02-13
10-K 2019-09-30 Filed 2020-01-16
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-17
10-Q 2018-12-31 Filed 2019-02-20
10-K 2018-09-30 Filed 2018-12-31
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-11
10-Q 2017-12-31 Filed 2018-02-14
10-K 2017-09-30 Filed 2017-12-01
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-04-17
10-Q 2016-12-31 Filed 2017-02-16
10-K 2016-09-30 Filed 2016-12-30
10-Q 2016-06-30 Filed 2016-08-19
10-Q 2016-03-31 Filed 2016-08-18
8-K 2020-04-14
8-K 2020-04-01
8-K 2020-03-02
8-K 2020-01-14
8-K 2019-12-09
8-K 2019-12-06
8-K 2019-11-28
8-K 2019-09-30
8-K 2019-02-01

Ando Holdings Financials

ANDO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703,462,000 4,932,953,000 139,834,000 0 -9,707,897,000 -9,659,520,000 -395,458,000
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240,249,000 43,296,964,000 1,764,009,000 374,238,000 -25,717,337,000 -18,297,230,000 -540,256,000
Poverty Dignified (POVD) 0.0 -4,053% 49,338,000 3,079,595,000 0 0 -1,999,816,000 -1,786,224,000 -40,929,000
Zhong Ya (WLUC) 0.0 0 62,889,000 0 0 -561,596,000 -561,596,000 -2,000
Weyland Tech (WEYL) 18% 2.2 -24% 11,699,111,000 2,217,605,000 24,630,065,000 4,371,806,000 -2,778,623,000 -2,702,174,000 -5,820,631,000
Longbau (LNGB) 4% -1.0 2% 10,659,548,000 10,135,830,000 4,882,008,000 209,757,000 164,602,000 221,914,000 -232,744,000
Scandium International Mining (SCY) 0.1 -171% 956,938,000 303,212,000 0 0 -1,636,126,000 -1,634,396,000 -219,146,000
Aprea Therapeutics (APRE) 8.4 -11% 57,336,058,000 9,942,725,000 0 0 -6,249,419,000 -6,249,419,000 -52,334,104,000
IntelliSense Solutions (INLL) 0.0 -7,286% 2,442,000 272,894,000 0 0 -177,936,000 -163,709,000 -2,444,000
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000,000,000 403,121,000,000,000 37,348,000,000,000 0 4,559,000,000,000 4,960,000,000,000 -8,986,000,001,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4,412,000 323,686,000 0 0 -28,634,000 -17,937,000 -4,414,000
Ando Holdings (ANDO) 1.1 -74% 73,214,000 159,843,000 0 0 -54,299,000 -53,972,000 -60,816,000
Po Yuen Cultural (POYE) 0.0 -1,973% 1,000,000 68,122,000 0 0 -19,731,000 -19,731,000 -2,000
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218,459,000 6,588,633,000 0 0 -701,078,000 -701,078,000 -10,879,000
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,577,822,000 65,986,000 14,700,000 0 -314,665,000 -314,640,000 -238,429,000
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130,000,000 54,472,808,000,000 0 0 132,964,000,000 1,095,234,000,000 32,380,960,999,000
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,276,504,000 5,549,239,000 -688,891,000 1,137,086,000 -4,981,415,000
Original Source Music (OSMU) 0.0 743,400% 35,313,000 0 0 -7,434,000 -7,434,000 -2,000
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076,020,000 1,126,459,000 0 0 0 4,713,000 -2,000
JiaLiJia Group (RZZN) 0.0 -1,721% 4,000,000 139,328,000 0 0 -68,826,000 -68,826,000 -2,000

Balance Sheet ($)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash550,00030,325,0004,050,0001,575,0004,070,00054,0000011,473,00062,136,00060,814,000
Accounts Receivable2,000,0004,000,000
Inventory
PP&E
Assets550,00031,280,0004,050,0003,575,0008,070,00054,0007,900,0005,165,0002,865,00012,000,0009,000,00017,473,00065,536,00073,214,000
Accounts Payable
Long-Term Debt
Liabilities7,768,00018,000,00019,445,00020,420,00021,045,00054,00016,650,00023,525,00028,270,00044,330,00048,993,00083,176,000142,018,000159,843,000
Stockholders' Equity-7,218,00013,280,000-15,395,000-16,845,000-12,975,000-8,750,000-18,360,000-25,405,000
Income Statement ($)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue0004,000,0006,000,0000000000
Cost of Revenue
Gross Profit
R&D
SG&A1,325,00015,801,00019,975,0001,600,0001,305,0004,715,000-3,585,0003,575,0003,495,0003,275,0004,013,0005,660,0005,330,0005,498,000
Tax00000000000000
Net Income-6,525,000-19,501,000-28,675,000-1,450,0003,495,000-9,865,000-8,750,000-9,610,000-6,790,000-6,925,000-7,663,000-25,710,000-10,779,000-10,147,000
Cash Flow ($)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-27,275,000-2,475,0002,495,000-26,865,000-14,150,000-8,575,000-5,145,000-16,025,000-5,063,000-17,520,000-10,837,000-17,898,000
Cash Investing
Cash Financing1,000,00014,096,0008,575,0005,145,00016,025,0005,063,00028,993,00061,500,00016,576,000